SHANG.FOS.PHARM.GR.H YC 1 (08HH) — Working Capital to Net Assets Ratio
SHANG.FOS.PHARM.GR.H YC 1 (08HH) has a Working Capital to Net Assets ratio of -4.1% as of March 2026. Working capital of €-2.62 Billion (current assets of €33.96 Billion minus current liabilities of €36.58 Billion) is measured against net assets of €63.67 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 08HH days of operational coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
SHANG.FOS.PHARM.GR.H YC 1 Working Capital to Net Assets (2021–2025)
This chart shows how SHANG.FOS.PHARM.GR.H YC 1's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at -4.1%, reflecting working capital of €-2.62 Billion against net assets of €63.67 Billion EUR. For the complete balance sheet picture, see SHANG.FOS.PHARM.GR.H YC 1 balance sheet assets.
Annual Working Capital to Net Assets for SHANG.FOS.PHARM.GR.H YC 1 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for SHANG.FOS.PHARM.GR.H YC 1 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check SHANG.FOS.PHARM.GR.H YC 1 liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -4.2% | €-2.60 Billion | €61.84 Billion | €33.82 Billion | €36.42 Billion | ▲ +0.7 pp |
| 2024 | -4.9% | €-2.96 Billion | €59.93 Billion | €34.49 Billion | €37.45 Billion | ▼ -5.0 pp |
| 2023 | 0.1% | €34.99 Million | €56.62 Billion | €33.79 Billion | €33.76 Billion | ▼ -3.6 pp |
| 2022 | 3.7% | €1.98 Billion | €54.11 Billion | €35.28 Billion | €33.30 Billion | ▲ +1.3 pp |
| 2021 | 2.3% | €1.12 Billion | €48.38 Billion | €30.44 Billion | €29.32 Billion | — |